|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 21,640.00 ARS | +1.84% |
|
+6.81% | +29.81% |
| 08-07 | Citigroup Adjusts Price Target on Amgen to $405 From $345, Maintains Neutral Rating | MT |
| 08-06 | Rothschild & Co Redburn Adjusts Amgen Price Target to $235 From $220, Maintains Sell Rating | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 222B | |||||
| 1,057B | |||||
| 625B | - | - | - | ||
| 435B | |||||
| 363B | |||||
| 296B |
- Stock Market
- Stocks
- AMGN Stock
- AMGN Stock
- Charts Amgen Inc.
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
